Sterling Accuris Launches ‘Accuris Express’, Offering 30-Minute Home Sample Collection in Ahmedabad

IMT News Desk
IMT News Desk
· 2 min read
Sterling Accuris launches Accuris Express in Ahmedabad, offering 30-minute home sample collection for faster, easier diagnostics.

Sterling Accuris has launched Accuris Express, a new home sample collection service that promises priority diagnostic sample collection within 30 minutes across Ahmedabad. The service is designed to make diagnostic testing faster, more convenient, and more responsive as demand for home-based healthcare continues to rise.

The new offering is being rolled out in Ahmedabad first, with a phased expansion planned across Gujarat. Through the Sterling Accuris Diagnostics website and app, users can book eligible tests and receive priority home sample collection by trained phlebotomists within 30 minutes in the city.

The company said the service is intended to meet a wide range of healthcare needs, from urgent and time-sensitive testing to routine preventive health checks. It is also expected to be especially useful for elderly patients, caregivers, families with young children, and working professionals who value convenience in accessing healthcare services.

Commenting on the launch, Mr. Ankush Gupta, CEO, Sterling Accuris, said, “We saw a clear disconnect between evolving consumer expectations and the traditional diagnostic experience. Accuris Express has been developed to bridge that gap by making access to diagnostic testing faster, simpler, and more convenient. As healthcare increasingly moves closer to the patient, we believe services that combine clinical reliability with greater convenience will play an important role in shaping the future of diagnostics.”

Mr. Rajiv Sharma, Managing Director, Sterling Accuris, added, “For many patients, the time between recognizing a health concern and getting tested can be frustrating. Accuris Express has been designed to reduce that gap by bringing trusted diagnostic services directly to patients’ homes. While speed is a key differentiator, our commitment to clinical accuracy, quality standards, and patient safety remains unchanged.”

Initially, Accuris Express will be available for select tests and locations in Ahmedabad, with further expansion planned across additional service areas and cities in Gujarat over time.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk